awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33557040-4036D3FA-E00E-4A1D-8585-6B52EF48373C
Q33557040-4036D3FA-E00E-4A1D-8585-6B52EF48373C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33557040-4036D3FA-E00E-4A1D-8585-6B52EF48373C
Endpoints in phase II trials for advanced non-small cell lung cancer.
P2860
Q33557040-4036D3FA-E00E-4A1D-8585-6B52EF48373C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33557040-4036D3FA-E00E-4A1D-8585-6B52EF48373C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de57c3828a41f59242f253c3cf360fd80d84147d
P2860
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.